Mangrove Partners’s Class Acceleration Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 CLAS.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-500,000
Closed -$4.94M 457
2022
Q3
$4.94M Hold
500,000
0.29% 121
2022
Q2
$4.91M Buy
+500,000
New +$62.5K 0.24% 140

Other funds holding CLAS.WS

Mangrove Partners's CLAS.WS Position: Q4 2022 in Review

Mangrove Partners sold out of Class Acceleration Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 (CLAS.WS) in Q4 2022, closing a stake of 500,000 shares — an estimated $4.94M sold.

Mangrove Partners first reported a position in CLAS.WS in Q2 2022 and held it in 2 quarters. The position peaked at $4.94M in Q3 2022. 1 fund tracked by Wall St. Rank holds CLAS.WS as of Q4 2022.

  • Mangrove Partners reported no remaining Class Acceleration Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • Mangrove Partners sold 500,000 Class Acceleration Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 shares in Q4 2022, an estimated $4.94M.
  • Mangrove Partners first reported a position in Class Acceleration Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 in Q2 2022 and held it in 2 quarters.
  • Mangrove Partners's Class Acceleration Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position peaked at $4.94M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Class Acceleration Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 as of Q4 2022.

Based on Mangrove Partners's 13F filing for Q4 2022, filed 14 Feb 2023.